08:06 EDT 20th March 2018 | BioPortfolio

Located in France, close to the biotech heart of Geneva, the CIPF is a part of Pierre FABRE Laboratories (over 9000 people in France and overseas).
Created in 1990, our Research Centre - 100 collaborators - is dedicated to the discovery, development and production of antibody-based molecules to treat cancer. Combining multiple research expertise in experimental oncology, genetic engineering, molecular and cellular biology, and biochemistry, together with a sound know-how in antibody humanization, cellular imaging, molecular modelling and bioinformatics.

In addition, the CIPF possesses an Industrial Pilot plant dedicated to process development and production of recombinant molecules of therapeutic interest.


5,avenue Napoléon III
St Julien en
Genevois Cedex,
BP 497, 74164


Phone: 33
Fax: 33

News Articles [371 Associated News Articles listed on BioPortfolio]

Pierre Fabre out-licenses F17727

Pierre Fabre Pharmaceuticals has entered into a worldwide licensing agreement for it selective potassium…

Institut Curie, Pierre Fabre Partner on immuno-oncology

Institut Curie and the IRPF (Institut de Recherche Pierre Fabre) will collaborate on new therapeutic strategies to advance cancer treatment for patients. The objective of this novel partnership is to ...

Boston Pharmaceuticals gets global rights to preclinical cardio compound from Pierre Fabre

Pierre Fabre Group licensed Boston Pharmaceuticals Inc. exclusive worldwide rights to develop, manufacture, and commercialize its selective potassium channel blocker F17727 for atrial fibrillation. ...

Cellectar and Pierre Fabre extend PDC deal

New Triple Combination Therapy Boosts Colorectal Cancer Survival

Pierre Fabre and Array BioPharma’s combination therapy for colorectal cancer has improved progression-free survival in a Phase III trial. French pharma Pierre Fabre and American biopharma Array...

Institut Curie, Pierre Fabre partner to develop cancer immunotherapies

BMG Pharma S.r.l Announces the Launch of Its AFTACURE Gel and AFTACURE Spray under the ELGYDIUM CLINIC Brand as Cicalium Gel and Cicalium Spray by its Partner Pierre Fabre Medicament in France

BMG Pharma S.r.l., an Italian specialty pharmaceutical company is pleased to announce that its partner, Pierre Fabre Laboratories, the second-largest French private pharmaceutical...

Array of excitement at combo’s comparison with Roche drug

USA-based Array BioPharma and privately-held French drugmaker Pierre Fabre have announced data showing…

PubMed Articles [379 Associated PubMed Articles listed on BioPortfolio]

The Pierre Robin Mandible is Hypoplastic and Morphologically Abnormal.

For Pierre Robin sequence (PRS) patients, there is incomplete characterization of 3D differences and effects of mandibular distraction osteogenesis (MDO) on the mandible compared to normal controls.

A comprehensive scoring system in correlation with perioperative airway management for neonatal Pierre Robin Sequence.

To evaluate a comprehensive scoring system which combines clinical manifestations of Pierre Robin Sequence (PRS) including severity of breathing difficulties, body weight and preoperative Cormack-Leha...

Postoperative Respiratory Complications After Cleft Palate Closure in Patients With Pierre Robin Sequence: Operative Considerations.

In cleft palate surgery, there is currently no consensus on the management of patients with Pierre Robin Sequence (PRS). The authors aimed to evaluate the treatment strategy of cleft palate in our cen...

Safety and Efficiency in a Canadian Outpatient Gynaecological Surgical Centre.

This study sought to describe safety and efficiency outcomes for patients undergoing procedures at the Women's Health Centre, an outpatient gynaecological surgical centre in Saskatoon, SK.

Differences in optimality index between planned place of birth in a birth centre and alternative planned places of birth, a nationwide prospective cohort study in The Netherlands: results of the Dutch Birth Centre Study.

To compare the Optimality Index of planned birth in a birth centre with planned birth in a hospital and planned home birth for low-risk term pregnant women who start labour under the responsibility of...

Clinical Trials [956 Associated Clinical Trials listed on BioPortfolio]

Efficacy and Tolerance of D-pigment Versus Moisturizer in Hands' Lentigo Lesions With or Without Laser Therapy

Pierre Fabre Dermo-Cosmétique has commercialized a cosmetic product (D-pigment rich texture) for treatment of hyperpigmentation. The aim of this study is to evaluate the efficacy of D-pig...

Impact of Phonatory and Facial Morphology Disorders, on the Quality of Life of Adolescents With Pierre Robin Sequence

The study team has made the hypothesis that the intensity of the phonatory disorders (rhinolalia), and of the maxillo-mandibular growth anomalies (facial morphology), may have negative eff...

Early Treatment Outcomes in Pierre-Robin-Like Phenotype

In a longitudinal cohort study, we want to assess the effect of the pre-epiglottic baton plate, the main treatment approach currently used in Germany for Pierre-Robin-Like phenotype, on up...

Brainstem Dysfunction Involvement in the Pathogenesis of Pierre Robin Sequence

Introduction Pierre Robin Sequence, PRS, incidence is about one hundred births per year in France. The main neonatal clinical manifestations are secondary to airway obstruction and food di...

A Multi-Centre Clinical Study in Chronic Spinal Cord Injury Patients

To establish a solid foundation, e.g. network and a coordinating centre for testing new SCI therapies in forthcoming randomized controlled multi-centre clinical trials following internatio...

Companies [373 Associated Companies listed on BioPortfolio]

Pierre Fabre SA

Pierre Fabre group, France's second biggest independent pharmaceutical laboratory, achieved a turnover of 1.75 billion euros in 2008. Approximatively 10,000 people including 1,400 in the research ...


Located in France, close to the biotech heart of Geneva, the CIPF is a part of Pierre FABRE Laboratories (over 9000 people in France and overseas). Created in 1990, our Research Centre - 100 collabor...

Groupe Pierre Fabre

The Pierre Fabre Group, the second largest independent French pharmaceutical company and leader in the field of in-pharmacy dermo-cosmetics, employs about 10,000 people worldwide, including 1,400 ...

Laboratoires Pierre Fabre S A



Supporting Food and Health industriesA specialist in stainless steel products and a designer and manufacturer of process vessels integrating sophisticated and innovative features in agitation, mixing,...

More Information about "CENTRE D’IMMUNOLOGIE PIERRE FABRE" on BioPortfolio

We have published hundreds of CENTRE D’IMMUNOLOGIE PIERRE FABRE news stories on BioPortfolio along with dozens of CENTRE D’IMMUNOLOGIE PIERRE FABRE Clinical Trials and PubMed Articles about CENTRE D’IMMUNOLOGIE PIERRE FABRE for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CENTRE D’IMMUNOLOGIE PIERRE FABRE Companies in our database. You can also find out about relevant CENTRE D’IMMUNOLOGIE PIERRE FABRE Drugs and Medications on this site too.

Quick Search


Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Corporate Database Quicklinks

Searches Linking to this Company Record